You are warmly invited to join us for the inaugural RCVS Fellowship Day, to be held on Wednesday, 19 October 2016 at 12pm in the prestigious surroundings of The Royal Institution in London.
In what promises to be an interesting and insightful afternoon, we shall be welcoming the first cohort of Fellows to be awarded under the new RCVS Fellowship initiative, and hearing from our keynote speaker, Consultant Medical Oncologist and Professor of Cancer Medicine Martin Gore CBE, about the ups and downs of research in practice.
All current RCVS Fellows are being invited to the Day, which should also present an excellent opportunity to hear about the new plans for the Fellowship and to exchange views and ideas over some afternoon tea.
Tickets (one per Fellow) are available on a first-come, first-served basis, and may be reserved by clicking on the green 'Register' button above.
We look forward to seeing you on the day.
12.00 – Registration and refreshments
12.30 – Welcome and opening remarks, Dr Bradley Viner
12.40 – Introducing the new RCVS Fellowship, Professor Nick Bacon
13.00 – Presentation of new Fellows, Dr Chris Tufnell
13.30 – Keynote address: ‘Research at the coalface: the pros and cons, the ups and the downs’, Professor Martin Gore CBE
14.15 – Closing remarks
14.30 – Afternoon Tea
16.00 – Close
Launched in April this year, the aim of the new Fellowship initiative is to advance and develop clinical and professional standards by providing a resource of independent knowledge for the benefit of the veterinary profession.
The criteria for achieving Fellowship includes sustained contribution to scholarship; producing a body of creative work that has been disseminated to others; indisputable advancement of their subject; providing leadership to the profession; and, advancement of the public understanding of the profession.
An oncologist for over 35 years, Professor Martin Gore is recognised both nationally and internationally for his work in melanoma, and ovarian and renal cancers. He is Professor of Cancer Medicine at The Institute of Cancer Research, and a Consultant Medical Oncologist in the gynaecological cancer, melanoma and kidney cancer units at The Royal Marsden.
After qualifying in medicine in 1974, he first worked at The Royal Marsden in 1978 as a Senior House Officer, starting a relationship with staff and patients of this world-leading institution that remains to this day.
In 2006, Professor Gore was appointed Medical Director, a post he held until stepping down in January this year. In 2015 he was awarded The Royal Marsden’s Lifetime Achievement Award.
His research interests remain the development of novel therapeutics in ovarian cancer, melanoma and renal cell carcinoma, particularly in the area of immunotherapy.